Clinical Trial Update: Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating docosahexaenoic acid (DHA) for metabolic effects in HIV patients on HAART. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Hypercholesterolemia
• Hiv-associated Hypertriglyceridemia
• Hiv-associated Inflammatory State

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: HIV-associated Hypertriglyceridemia, HIV-associated Hypercholesterolemia | Phase 3 | Status: COMPLETED